Bessemer Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$411K Sell
8,530
-486
-5% -$22.7K ﹤0.01% 1188
2025
Q4
$438K Buy
9,016
+2,614
+41% +$130K ﹤0.01% 1174
2025
Q3
$303K Buy
6,402
+512
+9% +$24.7K ﹤0.01% 1020
2025
Q2
$285K Buy
5,890
+1,551
+36% +$79.2K ﹤0.01% 1007
2025
Q1
$240K Buy
4,339
+3,692
+571% +$200K ﹤0.01% 1044
2024
Q4
$32K Buy
647
+242
+60% +$12.3K ﹤0.01% 1373
2024
Q3
$24K Sell
405
-464
-53% -$25.1K ﹤0.01% 1478
2024
Q2
$42K Buy
869
+11
+1% +$531 ﹤0.01% 1304
2024
Q1
$42K Sell
858
-3,188
-79% -$156K ﹤0.01% 1331
2023
Q4
$201K Buy
4,046
+1,947
+93% +$95.2K ﹤0.01% 1036
2023
Q3
$113K Buy
2,099
+144
+7% +$7.68K ﹤0.01% 1165
2023
Q2
$105K Buy
1,955
+1,294
+196% +$69.6K ﹤0.01% 1209
2023
Q1
$36K Sell
661
-58
-8% -$2.82K ﹤0.01% 1283
2022
Q4
$36K Sell
719
-2,314
-76% -$102K ﹤0.01% 1208
2022
Q3
$115K Buy
3,033
+2,059
+211% +$91.8K ﹤0.01% 1001
2022
Q2
$49K Sell
974
-1,569
-62% -$83.3K ﹤0.01% 1105
2022
Q1
$130K Sell
2,543
-2,160
-46% -$112K ﹤0.01% 923
2021
Q4
$236K Sell
4,703
-188
-4% -$9.3K ﹤0.01% 800
2021
Q3
$235K Sell
4,891
-5,387
-52% -$274K ﹤0.01% 744
2021
Q2
$541K Buy
10,278
+5,555
+118% +$290K ﹤0.01% 554
2021
Q1
$233K Buy
4,723
+1,761
+59% +$84.6K ﹤0.01% 724
2020
Q4
$144K Buy
2,962
+462
+18% +$22.8K ﹤0.01% 792
2020
Q3
$125K Sell
2,500
-171
-6% -$8.8K ﹤0.01% 808
2020
Q2
$137K Sell
2,671
-1,713
-39% -$83.3K ﹤0.01% 1192
2020
Q1
$191K Buy
4,384
+1,684
+62% +$80.6K ﹤0.01% 1004
2019
Q4
$136K Sell
2,700
-667
-20% -$31.2K ﹤0.01% 1137
2019
Q3
$156K Buy
3,367
+2,696
+402% +$116K ﹤0.01% 1106
2019
Q2
$29K Buy
671
+500
+292% +$21.3K ﹤0.01% 1386
2019
Q1
$8K Sell
171
-2,238
-93% -$95.9K ﹤0.01% 1538
2018
Q4
$104K Buy
2,409
+255
+12% +$11.2K ﹤0.01% 1144
2018
Q3
$96K Buy
2,154
+1,618
+302% +$69.1K ﹤0.01% 1130
2018
Q2
$22K Hold
536
﹤0.01% 1391
2018
Q1
$22K Sell
536
-271
-34% -$11.3K ﹤0.01% 1386
2017
Q4
$35K Sell
807
-600
-43% -$27.7K ﹤0.01% 1313
2017
Q3
$70K Buy
1,407
+900
+178% +$43.5K ﹤0.01% 1248
2017
Q2
$24K Buy
507
+271
+115% +$13K ﹤0.01% 1442
2017
Q1
$11K Sell
236
-6,718
-97% -$285K ﹤0.01% 1523
2016
Q4
$281K Buy
6,954
+2,347
+51% +$92.5K ﹤0.01% 1017
2016
Q3
$175K Buy
4,607
+1,162
+34% +$46.6K ﹤0.01% 999
2016
Q2
$144K Buy
3,445
+1,500
+77% +$61.5K ﹤0.01% 715
2016
Q1
$78K Sell
1,945
-351
-15% -$14.1K ﹤0.01% 824
2015
Q4
$98K Buy
2,296
+1,133
+97% +$52.1K ﹤0.01% 842
2015
Q3
$55K Sell
1,163
-1,871
-62% -$95.3K ﹤0.01% 939
2015
Q2
$150K Buy
3,034
+289
+11% +$14.6K ﹤0.01% 787
2015
Q1
$135K Sell
2,745
-3,514
-56% -$168K ﹤0.01% 786
2014
Q4
$285K Sell
6,259
-2,664,459
-100% -$129M ﹤0.01% 661
2014
Q3
$151M Buy
2,670,718
+38,915
+1% +$2.09M 0.85% 31
2014
Q2
$140M Buy
2,631,803
+41,202
+2% +$2.19M 0.86% 29
2014
Q1
$135M Buy
2,590,601
+144,387
+6% +$7.31M 0.91% 30
2013
Q4
$131M Buy
2,446,214
+70,139
+3% +$3.62M 0.94% 27
2013
Q3
$120M Buy
2,376,075
+56,842
+2% +$2.89M 0.98% 28
2013
Q2
$119M Buy
+2,319,233
New +$124M 1.07% 22

Other funds holding SNY

Bessemer Group's SNY Position: Q1 2026 in Review

Bessemer Group reduced its Sanofi (SNY) stake by 5.4% in Q1 2026, selling an estimated $22.7K and leaving 8,530 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Bessemer Group first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $151M in Q3 2014. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Bessemer Group held 8,530 shares of Sanofi worth $411K as of Q1 2026.
  • Bessemer Group sold 486 Sanofi shares in Q1 2026, an estimated $22.7K.
  • Sanofi made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #1188 holding.
  • Bessemer Group first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Bessemer Group's Sanofi position peaked at $151M in Q3 2014.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.